pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Fierce Biotech·12h ago·1 min read
save

BD appoints Ferass Abuzaina as Worldwide President of Surgery

Oct 9, 2026·read at Fierce Biotech ↗Positive

Becton, Dickinson and Company announced that Ferass Abuzaina will serve as the new Worldwide President of its Surgery business unit, effective immediately. He will oversee the global strategy, operations, and commercial performance of the Surgery segment and will report to Peter Menziuso, Executive Vice President and President of BD’s Interventional segment.

Abuzaina joins the role after a decade at BD, most recently as Worldwide Vice President and General Manager of Advanced Repair and Reconstruction within Surgery. His background spans research and development, strategy, and business development across several BD businesses, and he has been credited with advancing the Surgery innovation pipeline and improving commercial and operational performance.

The company’s leadership highlighted Abuzaina’s deep understanding of the business and commitment to innovation, stating that his appointment positions the Surgery unit for its next phase of growth and aims to enhance outcomes for patients and clinicians worldwide.

source

This writeup was produced by pharmadog from original reporting by Fierce Biotech.

Original headline: “Ferass Abuzaina named Worldwide President of Surgery at BD”

read at Fierce Biotech ↗
236 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
New York University
topics
Medical Device Company3

related stories

  • Jul 13Freenome colorectal cancer test data improve on earlier resultsBioPharma Dive
  • Jul 30Labcorp posts higher Q2 earnings on strength of diagnostics, lab services; adjusts full-year guidanceFierce Biotech
  • Jul 30GSK pens $110M biological datasets pact with AI biotech RelationFierce Biotech
  • Jul 30Boston Scientific cuts guidance again after unveiling restructuring planFierce Biotech
  • Jul 28Guardant Health taps Patrick Dempsey for emotional colorectal cancer awareness videoFierce Biotech